NeoDynamics was a publicly listed medical device company specializing in breast cancer diagnostics. Its flagship product, the NeoNavia Biopsy System, was acquired by NeoNavia AB. Following this transaction, NeoDynamics AB (publ) now operates under the name Gardienne Invest AB (publ).
| Website | https://www.gardienneinvest.com/ |
| Revenue | $5 million |
| Employees | 2 (2 on RocketReach) |
| Founded | 2015 |
| Address | Lejonvägen 14, Lidingoe, Stockholm, SE |
| Phone | +46 8 522 796 60 |
| Industry | Medical Equipment Manufacturing, Medical Devices & Equipment, Biopharma, Diagnostic Equipment, Manufacturing, Biotechnology, Therapeutic Devices, Health Care, Science and Engineering, Health Diagnostics |
| Web Rank | 14 Million |
| Keywords | Advanced Diagnostics, Medical Technology, Cancer Treatment, Breast Cancer, Biomedical Engineering, Cancer Diagnostics, Personalized Medicine, Surgical Navigation, Medical Devices, Healthcare Technology, Diagnostic Imaging, Oncology, Patient Care, Minimally Invasive, Treatment Optimization, Medical Innovation, Health Tech, Precision Medicine |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
Looking for a particular NeoDynamics employee's phone or email?
The NeoDynamics annual revenue was $5 million in 2026.
Aaron Wong is the CFO of NeoDynamics.
2 people are employed at NeoDynamics.
NeoDynamics is based in Lidingoe, Stockholm.
The SIC codes for NeoDynamics are [38, 384].